abrdn plc Sells 121,945 Shares of Axcelis Technologies, Inc. (NASDAQ:ACLS)

abrdn plc trimmed its position in shares of Axcelis Technologies, Inc. (NASDAQ:ACLS) by 78.5% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 33,327 shares of the semiconductor company’s stock after selling 121,945 shares during the quarter. abrdn plc owned approximately 0.10% of Axcelis Technologies worth $3,500,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Boston Trust Walden Corp acquired a new stake in Axcelis Technologies during the 3rd quarter worth approximately $53,099,000. Reinhart Partners LLC. lifted its holdings in shares of Axcelis Technologies by 64.1% during the third quarter. Reinhart Partners LLC. now owns 687,608 shares of the semiconductor company’s stock worth $72,096,000 after purchasing an additional 268,560 shares during the period. Vanguard Group Inc. grew its stake in shares of Axcelis Technologies by 6.5% in the first quarter. Vanguard Group Inc. now owns 4,304,516 shares of the semiconductor company’s stock worth $480,040,000 after purchasing an additional 263,604 shares during the last quarter. Granite Investment Partners LLC acquired a new stake in Axcelis Technologies in the second quarter valued at $27,801,000. Finally, Boston Partners bought a new position in Axcelis Technologies during the 1st quarter worth $20,819,000. 89.98% of the stock is currently owned by institutional investors.

Insider Activity at Axcelis Technologies

In other Axcelis Technologies news, Director Jorge Titinger sold 6,086 shares of the stock in a transaction that occurred on Tuesday, August 6th. The stock was sold at an average price of $109.98, for a total value of $669,338.28. Following the transaction, the director now owns 5,891 shares in the company, valued at approximately $647,892.18. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.43% of the stock is currently owned by corporate insiders.

Axcelis Technologies Stock Up 0.9 %

Shares of NASDAQ ACLS opened at $86.09 on Monday. The company’s fifty day simple moving average is $99.27 and its 200 day simple moving average is $113.74. Axcelis Technologies, Inc. has a 12-month low of $85.26 and a 12-month high of $158.61. The firm has a market cap of $2.81 billion, a PE ratio of 11.86, a P/E/G ratio of 2.57 and a beta of 1.60. The company has a quick ratio of 3.26, a current ratio of 4.42 and a debt-to-equity ratio of 0.05.

Analyst Ratings Changes

Several brokerages have recently weighed in on ACLS. Craig Hallum increased their price target on Axcelis Technologies from $130.00 to $174.00 and gave the company a “buy” rating in a research note on Friday, July 12th. Benchmark lowered their price target on shares of Axcelis Technologies from $180.00 to $175.00 and set a “buy” rating for the company in a report on Friday, August 2nd. B. Riley reduced their price objective on shares of Axcelis Technologies from $190.00 to $165.00 and set a “buy” rating on the stock in a research note on Friday, August 2nd. Bank of America lifted their target price on shares of Axcelis Technologies from $125.00 to $150.00 and gave the stock a “neutral” rating in a research note on Wednesday, July 10th. Finally, DA Davidson upped their price target on shares of Axcelis Technologies from $150.00 to $175.00 and gave the company a “buy” rating in a research report on Monday, July 15th. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat.com, Axcelis Technologies has an average rating of “Moderate Buy” and a consensus target price of $167.33.

About Axcelis Technologies

Axcelis Technologies, Inc designs, manufactures, and services ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe, and Asia Pacific. The company offers high energy, high current, and medium current implanters for various application requirements.